智數科技集團(01159.HK)擬折讓約19.52%配售最多2360萬股 淨籌3870萬港元
格隆匯7月4日丨智數科技集團(01159.HK)公告,於2025年7月4日,公司與配售代理訂立配售協議,據此,公司委任配售代理(作爲公司的獨家代理)盡最大努力於配售事項的先決條件獲達成後,按每股配售股份1.69港元的價格配售最多2360萬股配售股份予不少於六名承配人。
每股配售股份1.69港元的配售價較於配售協議日期聯交所所報收市價每股股份2.10港元折讓約19.52%;配售事項的所得款項淨額(經扣除可能由公司承擔的配售傭金、專業費用及所有相關開支)估計約爲3870萬港元。公司擬將該所得款項淨額用於償還集團債務,發展新的業務機會及補充營運資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.